News

Banning Noncompete Clauses Would Jeopardize U.S. Trade Competitiveness

February 15, 2023 No Comments

Former USPTO Head Criticizes Agency’s Approach To Pharma Patents

February 3, 2023 No Comments

Ex-USPTO Chiefs Say Patent System ‘Overhaul’ Not Needed

February 2, 2023 No Comments

In Response to Questions Signaling Major Changes to Patent System, Commenters Ask USPTO: ‘Where’s Your Data?’

February 2, 2023 No Comments

Former USPTO directors challenge Vidal’s patent outreach

February 2, 2023 No Comments

Hazards of Counterfeit Products, Record Low – or Is It?

December 22, 2022 No Comments

The IP News that Mattered Most in 2022, According to You

December 19, 2022 No Comments

WTO divided over expanding COVID-19 IP waiver

December 16, 2022 No Comments

C4IP Presents Webinar on COVID Waiver Extension

December 5, 2022 No Comments

Two former Commerce Department executives take on intellectual property protection

December 2, 2022 No Comments

Ex-IP Chiefs Urge US To Focus On Next Pandemic, Not Waiver

December 1, 2022 No Comments

Former Commerce, USPTO Heads Push for U.S. to Lead Opposition to Extending WTO’s COVID IP Waiver

December 1, 2022 No Comments

Banning Noncompete Clauses Would Jeopardize U.S. Trade Competitiveness

February 15, 2023

Former USPTO Head Criticizes Agency’s Approach To Pharma Patents

February 3, 2023

Ex-USPTO Chiefs Say Patent System ‘Overhaul’ Not Needed

February 2, 2023

In Response to Questions Signaling Major Changes to Patent System, Commenters Ask USPTO: ‘Where’s Your Data?’

February 2, 2023

Former USPTO directors challenge Vidal’s patent outreach

February 2, 2023

Hazards of Counterfeit Products, Record Low – or Is It?

December 22, 2022

The IP News that Mattered Most in 2022, According to You

December 19, 2022

WTO divided over expanding COVID-19 IP waiver

December 16, 2022

C4IP Presents Webinar on COVID Waiver Extension

December 5, 2022

Two former Commerce Department executives take on intellectual property protection

December 2, 2022

Ex-IP Chiefs Urge US To Focus On Next Pandemic, Not Waiver

December 1, 2022

Former Commerce, USPTO Heads Push for U.S. to Lead Opposition to Extending WTO’s COVID IP Waiver

December 1, 2022

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the ...

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

News

Banning Noncompete Clauses Would Jeopardize U.S. Trade Competitiveness

Former USPTO Head Criticizes Agency’s Approach To Pharma Patents

Ex-USPTO Chiefs Say Patent System ‘Overhaul’ Not Needed

In Response to Questions Signaling Major Changes to Patent System, Commenters Ask USPTO: ‘Where’s Your Data?’

Former USPTO directors challenge Vidal’s patent outreach

Hazards of Counterfeit Products, Record Low – or Is It?

The IP News that Mattered Most in 2022, According to You

WTO divided over expanding COVID-19 IP waiver

C4IP Presents Webinar on COVID Waiver Extension

Two former Commerce Department executives take on intellectual property protection

Ex-IP Chiefs Urge US To Focus On Next Pandemic, Not Waiver

Former Commerce, USPTO Heads Push for U.S. to Lead Opposition to Extending WTO’s COVID IP Waiver

Banning Noncompete Clauses Would Jeopardize U.S. Trade Competitiveness

Former USPTO Head Criticizes Agency’s Approach To Pharma Patents

Ex-USPTO Chiefs Say Patent System ‘Overhaul’ Not Needed

In Response to Questions Signaling Major Changes to Patent System, Commenters Ask USPTO: ‘Where’s Your Data?’

Former USPTO directors challenge Vidal’s patent outreach

Hazards of Counterfeit Products, Record Low – or Is It?

The IP News that Mattered Most in 2022, According to You

WTO divided over expanding COVID-19 IP waiver

C4IP Presents Webinar on COVID Waiver Extension

Two former Commerce Department executives take on intellectual property protection

Ex-IP Chiefs Urge US To Focus On Next Pandemic, Not Waiver

Former Commerce, USPTO Heads Push for U.S. to Lead Opposition to Extending WTO’s COVID IP Waiver

Contact

Menu